Status:
RECRUITING
Study of Late-foetal Human Organ Development
Lead Sponsor:
University College London Hospitals
Conditions:
Congenital Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Knowledge about abnormal organ development is important to understand pathology and to develop novel treatment approaches for individuals with congenital and acquired disease. Most of our current unde...
Eligibility Criteria
Inclusion
- ≥18 years old pregnant women who attend the Fetal Medicine Unit for concerns about a fetal abnormality where they decide to proceed to termination of pregnancy
Exclusion
- Screening labs positive for maternal HIV, Hepatitis B and Hepatitis C, Chlamydia and Herpes.
- Subject unable to make an informed decision about termination of pregnancy.
Key Trial Info
Start Date :
February 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04661059
Start Date
February 3 2022
End Date
December 31 2040
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospitals NHS Foundation Trust
London, United Kingdom